| Autor: |
Faour A; Department of Cardiology, Liverpool Hospital Sydney New South Wales.; The University of New South Wales Sydney New South Wales., Pahn R; The University of New South Wales Sydney New South Wales., Cherrett C; Department of Cardiology, Liverpool Hospital Sydney New South Wales., Gibbs O; Department of Cardiology, Liverpool Hospital Sydney New South Wales., Lintern K; Department of Cardiology, Liverpool Hospital Sydney New South Wales., Mussap CJ; Department of Cardiology, Liverpool Hospital Sydney New South Wales.; The University of New South Wales Sydney New South Wales.; Western Sydney University Sydney New South Wales., Rajaratnam R; Department of Cardiology, Liverpool Hospital Sydney New South Wales.; The University of New South Wales Sydney New South Wales.; Western Sydney University Sydney New South Wales., Leung DY; Department of Cardiology, Liverpool Hospital Sydney New South Wales.; The University of New South Wales Sydney New South Wales.; Western Sydney University Sydney New South Wales., Taylor DA; Department of Cardiology, Liverpool Hospital Sydney New South Wales., Faddy SC; New South Wales Ambulance Sydney New South Wales., Lo S; Department of Cardiology, Liverpool Hospital Sydney New South Wales.; The University of New South Wales Sydney New South Wales.; Western Sydney University Sydney New South Wales., Juergens CP; Department of Cardiology, Liverpool Hospital Sydney New South Wales.; The University of New South Wales Sydney New South Wales., French JK; Department of Cardiology, Liverpool Hospital Sydney New South Wales.; The University of New South Wales Sydney New South Wales.; Western Sydney University Sydney New South Wales.; Ingham Institute Sydney New South Wales. |
| Abstrakt: |
Background Patients with suspected ST-segment-elevation myocardial infarction (STEMI) and cardiac catheterization laboratory nonactivation (CCL-NA) or cancellation have reportedly similar crude and higher adjusted risks of death compared with those with CCL activation, though reasons for these poor outcomes are not clear. We determined late clinical outcomes among patients with prehospital ECG STEMI criteria who had CCL-NA compared with those who had CCL activation. Methods and Results We identified consecutive prehospital ECG transmissions between June 2, 2010 to October 6, 2016. Diagnoses according to the Fourth Universal Definition of myocardial infarction (MI), particularly rates of myocardial injury, were adjudicated. The primary outcome was all-cause death. Secondary outcomes included cardiovascular death/MI/stroke and noncardiovascular death. To explore competing risks, cause-specific hazard ratios (HRs) were obtained. Among 1033 included ECG transmissions, there were 569 (55%) CCL activations and 464 (45%) CCL-NAs (1.8% were inappropriate CCL-NAs). In the CCL activation group, adjudicated index diagnoses included MI (n=534, 94%, of which 99.6% were STEMI and 0.4% non-STEMI), acute myocardial injury (n=15, 2.6%), and chronic myocardial injury (n=6, 1.1%). In the CCL-NA group, diagnoses included MI (n=173, 37%, of which 61% were non-STEMI and 39% STEMI), chronic myocardial injury (n=107, 23%), and acute myocardial injury (n=47, 10%). At 2 years, the risk of all-cause death was higher in patients who had CCL-NA compared with CCL activation (23% versus 7.9%, adjusted risk ratio, 1.58, 95% CI, 1.24-2.00), primarily because of an excess in noncardiovascular deaths (adjusted HR, 3.56, 95% CI, 2.07-6.13). There was no significant difference in the adjusted risk for cardiovascular death/MI/stroke between the 2 groups (HR, 1.23, 95% CI, 0.87-1.73). Conclusions CCL-NA was not primarily attributable to missed STEMI, but attributable to "masquerading" with high rates of non-STEMI and myocardial injury. These patients had worse late outcomes than patients who had CCL activation, mainly because of higher rates of noncardiovascular deaths. |
Plný text